Skip to main content

Health Care Enforcement Review & 2017 Outlook

Jan
25
2017

Date: January 25, 2017

Time: 1:00PM

Location: Webinar

 

In 2016, the government demonstrated through both civil and criminal actions that health care fraud enforcement remains a top priority. In this annual webinar and the accompanying blog series, Mintz Levin’s Health Care Enforcement Defense Team will review the key government policies, regulations, and enforcement actions from 2016, and the likely impact of these trends on enforcement in 2017.

Topics will include:

  • The increase in enforcement attention regarding individuals as a result of the Yates Memo
  • Key case developments, including 1) the Supreme Court’s decision in Escobar and the impact of this opinion; 2) AseraCare and proving falsity in False Claims Act cases premised on a lack of medical necessity; and 3) the use of statistical sampling to prove liability
  • The impact of the 60-day overpayment rule for reverse False Claims Act liability
  • Notable settlements from 2016 and what they may tell us about enforcement in 2017
  • The forecasted effects of the substantial increase in False Claims Act penalties

 

Speakers

Professional Croppe Beirne Eoin Mintz

Eoin P. Beirne

Panelist

Eóin P. Beirne is a white collar defense lawyer at Mintz. He guides clients from a wide range of industries through investigations and enforcement proceedings and represents them in state and federal courts. Eóin handles matters related to health care fraud, public corruption, and insider trading.
Professional Cropped Foster Hope Mintz

Hope S. Foster

Panelist

Hope S. Foster is a health care enforcement defense lawyer with a national reputation. She's Chair of the Mintz Health Care Enforcement Practice, where she defends clients in governmental investigations. Hope also advises health care providers and manufacturers on enforcement issues.
Karen S. Lovitch is a Mintz attorney who represents health care companies in regulatory, transactional, and operational matters. She advises them on health care regulations such as the Stark Law and the Clinical Laboratory Improvement Amendments of 1988.